Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Accumulated Expenses (2019 - 2025)

AVITA Medical filings provide 7 years of Accumulated Expenses readings, the most recent being $7.8 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 25.24% to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a 25.24% decrease, with the full-year FY2025 number at $7.8 million, down 25.24% from a year prior.
  • Accumulated Expenses hit $7.8 million in Q4 2025 for AVITA Medical, up from $5.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.5 million in Q4 2024 to a low of $2.5 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $6.0 million (2023), compared with a mean of $6.1 million.
  • Biggest five-year swings in Accumulated Expenses: soared 58.34% in 2024 and later tumbled 40.72% in 2025.
  • AVITA Medical's Accumulated Expenses stood at $5.4 million in 2021, then rose by 23.49% to $6.6 million in 2022, then rose by 20.37% to $8.0 million in 2023, then surged by 31.1% to $10.5 million in 2024, then decreased by 25.24% to $7.8 million in 2025.
  • The last three reported values for Accumulated Expenses were $7.8 million (Q4 2025), $5.8 million (Q3 2025), and $7.9 million (Q2 2025) per Business Quant data.